FDA Official: Enforcement Crackdown Is Moving Quickly
August 26, 2009
FDA Official: Enforcement Crackdown Is Moving Quickly
The FDA in the latest several months has employed a extended array of tools — a consent statute, drug seizures and 68 warning culture about products to treat influenza A (H1N1) — to accelerate its stricter enforcement campaign. For bring forward as an example, a June seizure of products from Caraco Pharmaceutical Laboratories occurred six weeks from an FDA inspection, Edwin Rivera-Martinez, chief of the international compliance branch in CDER’s division of manufacturing and compliance, said at the 14th Annual GMP by dint of. the Sea conference in Cambridge, Md.

